Mind CBD Fleurs CBD 2 Grammes Orange Bud (Indoor) - CBD 15,5%
View 3 heads Orange Bud
Mind CBD Flower Bag
Mind CBD Fleurs CBD Orange Bud (Indoor) - CBD 15,5%

Orange Bud (Indoor) - CBD 15,5%

A great Californian classic, Orange Bud reveals notes of citrus, pine and a skunky touch. Grown indoors and hand-harvested, this highly aromatic flower boasts 15.5% CBD.
Regular price 13,80 € Sale price instead of 18,00 €

Availability: In stock – Ships within 24h

6,90 €/g
Tax included. Shipping calculated at checkout.
En Stock !
Livré en France sous 2 à 3 jours
Vous n'êtes pas en France ?

Summary

Orange Bud CBD Flowers, Switzerland, Indoor

  • Grown indoors in Switzerland (Indoor)
  • Flavours: Citrus, Skunky, Pine
  • CBD 15.5%
  • Sativa-dominant hybrid
  • Hand-harvested

See all products:

Details

Orange Bud CBD Flowers, Switzerland, Indoor

A Californian classic, popular with many enthusiasts.

Cultivation method
Organic cultivation carried out indoors (Indoor) in Switzerland, then hand-harvested.

Species
Sativa-dominant hybrid.

Concentration

  • CBD: 15.5%
  • THC: 0.23%

Certification
Orange Bud CBD grown in the EU, then certified by an independent, GMP-approved laboratory.

Legislation
100% legal product in the European Union. This variety is a hybrid derived from varieties authorised in the European catalogue.

*Photos are non-contractual, taken by us and from the batch currently on sale*

Flavours

Orange Bud CBD, Switzerland, Indoor

  • Citrus
  • Skunky
  • Pine

Origins

Born in California in the mid-1970s, Orange Bud, from the large Skunk family, arrived in Holland in the 1980s. The cross was originally 75% Sativa and 25% Indica. The Orange Bud CBD flower is therefore a Sativa-dominant hybrid variety.

Its dense, thick flowers have a tangy citrus aroma and are covered in orange trichomes, which gave this famous variety its name.

Similar products

Discover other Indoor CBD flowers:

Sources and references (4)

Official and scientific sources on the regulation, safety, composition and quality of this type of product. They are provided for information and are not health claims.

  1. MILDECA (2021). L'indispensable sur... le cannabidiol (CBD). MILDECA — drogues.gouv.fr. View the source
  2. MILDECA (2023). Le CBD. drogues.gouv.fr (Mission interministérielle de lutte contre les drogues et les conduites addictives). View the source
  3. Chevallier C, Charuel L, Richeval C, Chaouachi L, Del Valle L, Eiden C, Gaulier JM, Batisse A (CEIP-A Paris, Lyon, Montpellier ; CHU Lille) (2023). Cannabidiol : analyse de produits « CBD non pharmaceutiques » disponibles sur le marché en France. MILDECA — drogues.gouv.fr (rapport CEIP-A financé par la MILDECA). View the source
  4. Dryburgh LM, Bolan NS, Grof CPL, et al. (2018). Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. British Journal of Clinical Pharmacology. View the source

Recently viewed